Show simple item record

dc.contributor.authorYeh, Hung-Wen
dc.contributor.authorEllerbeck, Edward F
dc.contributor.authorMahnken, Jonathan D
dc.date.accessioned2015-05-27T09:55:07Z
dc.date.available2015-05-27T09:55:07Z
dc.date.issued2012-07-07en_US
dc.identifier.urihttp://hdl.handle.net/2271/1328en_US
dc.description.abstractAbstract Background GEE and mixed models are powerful tools to compare treatment effects in longitudinal smoking cessation trials. However, they are not capable of assessing the relapse (from abstinent back to smoking) simultaneously with cessation, which can be studied by transition models. Methods We apply a first-order Markov chain model to analyze the transition of smoking status measured every 6 months in a 2-year randomized smoking cessation trial, and to identify what factors are associated with the transition from smoking to abstinent and from abstinent to smoking. Missing values due to non-response are assumed non-ignorable and handled by the selection modeling approach. Results Smokers receiving high-intensity disease management (HDM), of male gender, lower daily cigarette consumption, higher motivation and confidence to quit, and having serious attempts to quit were more likely to become abstinent (OR = 1.48, 1.66, 1.03, 1.15, 1.09 and 1.34, respectively) in the next 6 months. Among those who were abstinent, lower income and stronger nicotine dependence (OR = 1.72 for ≤ vs. > 40 K and OR = 1.75 for first cigarette ≤ vs. > 5 min) were more likely to have relapse in the next 6 months. Conclusions Markov chain models allow investigation of dynamic smoking-abstinence behavior and suggest that relapse is influenced by different factors than cessation. The knowledge of treatments and covariates in transitions in both directions may provide guidance for designing more effective interventions on smoking cessation and relapse prevention. Trial Registration clinicaltrials.gov identifier: NCT00440115
dc.titleSimultaneous evaluation of abstinence and relapse using a Markov chain model in smokers enrolled in a two-year randomized trial
dc.typeArticleen_US
dc.identifier.doi10.1186/1471-2288-12-95en_US
dc.date.updated2013-03-14T16:09:58Z
dc.description.versionPeer Reviewed
dc.rights.holderHung-Wen Yeh et al.; licensee BioMed Central Ltd.
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record